Bioconjugated nanoparticles for attachment and penetration into pathogenic bacteria

Biomaterials

Volumn 34, Issue 38, 2013, Pages 10328-10337

  Mei, Lin ^a   Lu, Zhentan ^a   Zhang, Wei ^a   Wu, Zhongming ^b   Zhang, Xinge ^a   Wang, Yanan ^a   Luo, Yuting ^a   Li, Chaoxing ^a   Jia, Yanxia ^c  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Antibacterial material; Antimicrobial mechanism; Bacitracin A; Bacterial infection; Polymyxin E; Silver nanoparticles

Indexed keywords

ANTIBACTERIAL MATERIALS; ANTIMICROBIAL MECHANISMS; BACITRACIN A; BACTERIAL INFECTIONS; POLYMYXIN E; SILVER NANOPARTICLES;

ANTIBIOTICS; ANTIMICROBIAL AGENTS; BACTERIA; BIOCOMPATIBILITY; CELL MEMBRANES; CYTOLOGY; NANOPARTICLES; SYNTHESIS (CHEMICAL);

SILVER;

BACITRACIN; BACITRACIN A; COLISTIN; SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL VIABILITY; BACTERIUM ADHERENCE; BIOCOMPATIBILITY; CELL VIABILITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DESIGN; DRUG MECHANISM; DRUG PENETRATION; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; WOUND HEALING; WOUND INFECTION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

ANTIBACTERIAL MATERIAL; ANTIMICROBIAL MECHANISM; BACITRACIN A; BACTERIAL INFECTION; POLYMYXIN E; SILVER NANOPARTICLES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACITRACIN; COLISTIN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MALE; METAL NANOPARTICLES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NIH 3T3 CELLS; RATS; RATS, WISTAR; SILVER;

EID: 84885375706     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.045     Document Type: Article

References (49)

1. Mahmoudi M., Serpooshan V. Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. ACS Nano 2012, 6:2656-2664.
2. Curcio D. Resistant pathogen-associated skin and skin-structure infections: antibiotic options. Expert Rev Anti Infect Ther 2010, 8:1019-1036.
3. Chen X., Schluesener H.J. Nanosilver: a nanoproduct in medical application. Toxicol Lett 2008, 176:1-12.
4. Seoktae K. Single-walled carbon nanotubes exhibit strong antimicrobial activity. Langmuir 2007, 23:8670-8673.
5. Lyon D.Y., Fortner J.D., Sayes C.M., Colvin V.L., Hughe J.B. Bacterial cell association and antimicrobial activity of a C60 water suspension. Environ Toxicol Chem 2005, 24:2757-2762.
6. Kumar A., Pandey A.K., Singh S.S., Shanker R., Dhawan A. Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells. Chemosphere 2011, 83:1124-1132.
7. Morones J.R., Elechiguerra J.L., Camacho A., Holt K., Kouri J.B., Ramirez J.T., et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
8. Rycenga M., Cobley C.M., Zeng J., Li W.Y., Moran C.H., Zhang Q., et al. Controlling the synthesis and assembly of silver nanostructures for plasmonic applications. Chem Rev 2011, 111:3669-3712.
9. Xu X.H., Brownlow W.J., Kyriacou S.V., Wan Q., Viola J.J. Real-time probing of membrane transport in living microbial cells using single nanoparticle optics and living cell imaging. Biochemistry 2004, 43:10400-10413.
10. Lara H.H., Garza-Treviño E.N., Ixtepan-Turrent L., Singh D.K. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. JNanobiotechnol 2011, 9:30-37.
11. Zhang Y.W., Peng H.S., Huang W., Zhou Y.F., Zhang X.H., Yan D.Y. Hyperbranched poly(amidoamine) as the stabilizer and reductant to prepare colloid silver nanoparticles in situ and their antibacterial activity. JPhys Chem C 2008, 112:2330-2336.
12. Lv H., Zhang S., Wang B., Cui S., Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. JControl Release 2006, 114:100-109.
13. Cai J.G., Yue Y.N., Rui D., Zhang Y.F., Liu S.Y., Wu C. Effect of chain length on cytotoxicity and endocytosis of cationic polymers. Macromolecules 2011, 44:2050-2057.
14. Maillard J.Y. Bacterial target sites for biocide action. JAppl Microbiol 2002, 92:16S-27S.
15. Liu L.H., Xu K.J., Wang H.Y., Tan P.K.J., Fan W.M., Venkatraman S.S., et al. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat Nanotechnol 2009, 4:457-463.
16. Wang H.Y., Xu K.J., Liu L.H., Tan J.P.K., Chen Y.B., Li Y.T., et al. The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. Biomaterials 2010, 31:2874-2881.
17. D'Amato R.F., Thornsberry C., Baker C.N., Kirven L.A. Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin, polymyxin B, and carbenicillin. Antimicrob Agents Chemother 1975, 7:596-600.
18. Ramirez-Ronda C.H., Holmes R.K., Sanford J.P. Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria. Antimicrob Agents Chemother 1975, 7:239-245.
19. Chen X.Y., Tang H.Z., Even M.A., Wang J., Tew G.N., Chen Z. Observing a molecular knife at work. JAm Chem Soc 2006, 128:2711-2714.
20. Petty J.T., Zheng J., Hud N.V., Dickson R.M. DNA-templated Ag nanocluster formation. JAm Chem Soc 2004, 126:5207-5212.
21. Jones M.R., Osberg K.D., Macfarlane R.J., Langille M.R., Mirkin C.A. Templated techniques for the synthesis and assembly of plasmonic nanostructures. Chem Rev 2011, 111:3736-3827.
22. Hamilton-Miller J.M., Shah S., Smith C. Silver sulphadiazine: a comprehensive invitro reassessment. Chemotherapy 1993, 39:405-409.
23. Haiss W., Thanh N.T.K., Aveyard J., Fernig D.G. Determination of size and concentration of gold nanoparticles from UV-Vis spectra. Anal Chem 2007, 79:4215-4221.
24. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2006, Approved Standard-Seventh Edition. Clinical and Laboratory Standards Institute document M7-A7, Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA.
25. Kumar S.N., Siji J.V., Nambisan B., Mohandas C. Activity and synergistic interactions of stilbenes and antibiotic combinations against bacteria invitro. World J Microbiol Biotechnol 2012, 28:3143-3150.
26. Koepsel R.R., Russell A.J. Directed capture of enzymes and bacteria on bioplastic films. Biomacromolecules 2003, 4:850-855.
27. Kim J.S., Kuk E., Yu K.N., Kim J.H., Park S.J., Lee H.J., et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007, 3:95-101.
28. Gorham J.M., Mac Cuspie R.I., Klein K.L., Fairbrother D.H., Holbrook R.D. UV-induced photochemical transformations of citrate capped silver nanoparticle suspensions. JNanopart Res 2012, 14:1139-1155.
29. Wolff H., Gamer G. Hydrogen bonding and complex formation of dimethylamine. Infrared investigations on the NH stretching vibration bands. JPhys Chem 1972, 76:871-876.
30. Wen X., Xie Y.T., Mak M.W., Cheung K.Y., Li X.Y., Renneberg R., et al. Dendritic nanostructures of silver: facile synthesis, structural characterizations, and sensing applications. Langmuir 2006, 22:4836-4842.
31. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 2005, 3:238-250.
32. Hancock R.E.W. Alterations in outer membrane permeability. Annu Rev Microbiol 1984, 38:237-264.
33. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother 1989, 33:1831-1836.
34. Nikaido H., Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev 1985, 49:1-32.
35. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev 1992, 56:395-411.
36. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 2003, 67:593-656.
37. Moore R.A., Bates N.C., Hancock R.E. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob Agents Chemother 1986, 29:496-500.
38. Lambert P.A., Hancock I.C., Baddiley J. The interaction of magnesium ions with teichoic acid. Biochem J 1975, 149:519-524.
39. Braun V., Hantke K. Biochemistry of bacterial cell envelopes. Annu Rev Biochem 1974, 43:89-121.
40. Kiyota H., Kendrick M.I., Kass E.H. Influence of magnesium concentration on production of exoprotein and β-Lactamase by Staphylococcus aureus and Staphylococcus hemolyticus. JInfect Dis 1989, 160:1061-1063.
41. Manafi M., Kneifel W., Bascomb S. Fluorogenic and chromogenic substrates used in bacterial diagnostics. Microbiol Mol Biol Rev 1991, 55:335-348.
42. Taglietti A., Diaz Fernandez Y.A., Amato E., Cucca L., Dacarro G., Grisoli P., et al. Antibacterial activity of glutathione-coated silver nanoparticles against gram positive and gram negative bacteria. Langmuir 2012, 28:8140-8148.
43. Kadurugamuwa J.L., Clarke A.J., Beveridge T.J. Surface action of gentamicin on Pseudomonas aeruginosa. JBacteriol 1993, 175:5798-5805.
44. Carlson C., Hussain S.M., Schrand A.M., Braydich-Stolle L.K., Hess K.L., Jones R.L., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. JPhys Chem B 2008, 112:13608-13619.
45. Santoro C.M., Duchsherer N.L., Grainger D.W. Antimicrobial efficacy and ocular cell toxicity from silver nanoparticles. Nanobiotechnology 2007, 3:55-65.
46. Lok C.N., Ho C.M., Chen R., He Q.Y., Yu W.Y., Sun H., et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. JProteome Res 2006, 5:916-924.
47. Butler M.T., Wang Q.F., Harshey R.M. Cell density and mobility protect swarming bacteria against antibiotics. Proc Natl Acad Sci U S A 2010, 107:3776-3781.
48. Beer C., Foldbjerg R., Hayashi Y., Sutherland D.S., Autrup H. Toxicity of silver nanoparticles-nanoparticle or silver ion?. Toxicol Lett 2012, 208:286-292.
49. Li J., Turnidge J., Milne R., Nation R.L., Coulthard K. Invitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 2001, 45:781-785.